Panpulimab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Panpulimab, covering 2026-02-19 to 2026-02-19. Get the full timeline:
Most recent: Clinical Trial Update: Re-challenge Immunotherapy With Cromolyn, TQB2102, and Panpulimab in Immune-Refractory Triple Negative Breast Cancer [Phase 2]